155 related articles for article (PubMed ID: 36940862)
21. Interferon regulatory factor 7 inhibits rat vascular smooth muscle cell proliferation and inflammation in monocrotaline-induced pulmonary hypertension.
Deng Y; Guo SL; Li JQ; Xie SS; Zhou YC; Wei B; Wang Q; Wang F
Life Sci; 2021 Jan; 264():118709. PubMed ID: 33152351
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of ACE2 prevents hypoxia-induced pulmonary hypertension in rats by inhibiting proliferation and immigration of PASMCs.
Hu HH; Zhang RF; Dong LL; Chen EG; Ying KJ
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3968-3980. PubMed ID: 32329874
[TBL] [Abstract][Full Text] [Related]
23. Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress.
Pan J; Wang R; Pei Y; Wang D; Wu N; Ji Y; Tang Q; Liu L; Cheng K; Liu Q; Sun J; Gong M; Zheng X; Li J; Zhang C; Yuan Y
J Nutr Biochem; 2023 Jan; 111():109182. PubMed ID: 36220525
[TBL] [Abstract][Full Text] [Related]
24. Astragaloside IV attenuates hypoxia‑induced pulmonary vascular remodeling via the Notch signaling pathway.
Yao J; Fang X; Zhang C; Yang Y; Wang D; Chen Q; Zhong G
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236156
[TBL] [Abstract][Full Text] [Related]
25. [Effect of platelet-derived growth factor-BB on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension and its mechanism].
Guo X; Li MX; Bayer C; Yang YQ; Wang L
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Apr; 25(4):407-414. PubMed ID: 37073847
[TBL] [Abstract][Full Text] [Related]
26. Salidroside blocks the proliferation of pulmonary artery smooth muscle cells induced by platelet‑derived growth factor‑BB.
Chen C; Tang Y; Deng W; Huang C; Wu T
Mol Med Rep; 2014 Aug; 10(2):917-22. PubMed ID: 24840151
[TBL] [Abstract][Full Text] [Related]
27. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
28. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
[TBL] [Abstract][Full Text] [Related]
29. The effects of the 5-HT2A receptor antagonist sarpogrelate hydrochloride on chronic hypoxic pulmonary hypertension in rats.
Geng J; Fan FL; He S; Liu Y; Meng Y; Tian H; Zhang D; Ma Q; Zhang JB; Tian HY
Exp Lung Res; 2016 May; 42(4):190-8. PubMed ID: 27191897
[TBL] [Abstract][Full Text] [Related]
30. Vascular peroxidase 1 mediates hypoxia-induced pulmonary artery smooth muscle cell proliferation, apoptosis resistance and migration.
You B; Liu Y; Chen J; Huang X; Peng H; Liu Z; Tang Y; Zhang K; Xu Q; Li X; Cheng G; Shi R; Zhang G
Cardiovasc Res; 2018 Jan; 114(1):188-199. PubMed ID: 29186367
[TBL] [Abstract][Full Text] [Related]
31. OPN silencing reduces hypoxic pulmonary hypertension via PI3K-AKT-induced protective autophagy.
Zhou R; Li R; Ding Q; Zhang Y; Yang H; Han Y; Liu C; Liu J; Wang S
Sci Rep; 2024 Apr; 14(1):8670. PubMed ID: 38622371
[TBL] [Abstract][Full Text] [Related]
32. Restoration of miR-328a-5p function curtails hypoxic pulmonary hypertension through a mechanism involving PIN1/GSK3β/β-catenin axis.
Yuan J; Li S; Han Y; Li F; Shi H; Shi W; Cui W
Int Immunopharmacol; 2023 Oct; 123():110599. PubMed ID: 37567011
[TBL] [Abstract][Full Text] [Related]
33. Crosstalk between the Akt/mTORC1 and NF-κB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs.
Li Y; Yang L; Dong L; Yang ZW; Zhang J; Zhang SL; Niu MJ; Xia JW; Gong Y; Zhu N; Zhang XJ; Zhang YY; Wei XM; Zhang YZ; Zhang P; Li SQ
Acta Pharmacol Sin; 2019 Oct; 40(10):1322-1333. PubMed ID: 31316183
[TBL] [Abstract][Full Text] [Related]
34. The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development.
Li J; Jia M; Liu M; Cao Z; Wang X; Feng N; Gu X; Zhang S; Fan R; Guo H; Wang Y; Liu M; Pei J
Biomed Pharmacother; 2020 May; 125():109931. PubMed ID: 32066040
[TBL] [Abstract][Full Text] [Related]
35. Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats.
Xu DQ; Luo Y; Liu Y; Wang J; Zhang B; Xu M; Wang YX; Dong HY; Dong MQ; Zhao PT; Niu W; Liu ML; Gao YQ; Li ZC
Respir Res; 2010 Dec; 11(1):182. PubMed ID: 21182801
[TBL] [Abstract][Full Text] [Related]
36. Resistin-like molecule β acts as a mitogenic factor in hypoxic pulmonary hypertension via the Ca
Tian H; Liu L; Wu Y; Wang R; Jiang Y; Hu R; Zhu L; Li L; Fang Y; Yang C; Ji L; Liu G; Dai A
Respir Res; 2021 Jan; 22(1):8. PubMed ID: 33407472
[TBL] [Abstract][Full Text] [Related]
37. Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells.
Jin H; Wang Y; Zhou L; Liu L; Zhang P; Deng W; Yuan Y
J Pineal Res; 2014 Nov; 57(4):442-50. PubMed ID: 25251287
[TBL] [Abstract][Full Text] [Related]
38. Quercetin reverses experimental pulmonary arterial hypertension by modulating the TrkA pathway.
He Y; Cao X; Liu X; Li X; Xu Y; Liu J; Shi J
Exp Cell Res; 2015 Nov; 339(1):122-34. PubMed ID: 26476374
[TBL] [Abstract][Full Text] [Related]
39. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
[TBL] [Abstract][Full Text] [Related]
40. DNA-PKcs participated in hypoxic pulmonary hypertension.
Liu YY; Zhang WY; Zhang ML; Wang YJ; Ma XY; Jiang JH; Wang R; Zeng DX
Respir Res; 2022 Sep; 23(1):246. PubMed ID: 36114572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
